Tag: Necrotic tissue

Enzymatic debridement, a method for treating wounds with non-viable tissue, has been a component of wound care for decades. A key example of this therapy is trypsin cream, which uses a proteolytic enzyme to selectively dissolve dead tissue, preparing the wound bed for optimal healing.

For over 50 years, the FDA-approved prescription ointment Santyl has been used to help debride and prepare chronic dermal ulcers and severe burns for healing. But **how does Santyl work** to effectively and selectively remove necrotic tissue without harming healthy skin, and why is this critical for the healing process? This guide explores the unique enzymatic mechanism that makes it a trusted option in wound care.

Iruxol ointment is an enzyme-based preparation used for the breakdown of necrotic tissue in wounds [1.5.5, 1.2.5]. So, what are the ingredients in Iruxol cream that make it effective for wound cleaning and healing?

With over 20 years of successful use in wound treatment, Iruxol mono pomada is a proven enzymatic ointment used for gentle and selective removal of necrotic tissue. This medication's active components work to cleanse the wound bed, clearing a path for the body's natural healing processes to take hold.

Approximately 6.5 million people in the U.S. are affected by chronic wounds annually, often complicated by dead, or necrotic, tissue [1.7.1, 1.7.3]. This article explores the question, 'What is Iruxol cream used for?'—a medication designed to address this very problem through enzymatic action.